- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 181 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 186 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 188 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 193 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- August 2024
- 100 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2024
- 125 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- April 2025
- 180 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 62 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 85 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 73 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 197 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 381 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2024
- 468 Pages
Global
From €4298EUR$4,799USD£3,664GBP

Targeted sequencing is a type of genomics technology that focuses on specific regions of the genome. It is used to identify genetic variants associated with diseases, to detect mutations in cancer, and to study gene expression. Targeted sequencing is a cost-effective alternative to whole-genome sequencing, as it requires less sequencing and data analysis. It is also used in clinical diagnostics, drug discovery, and agricultural research.
Targeted sequencing is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more